188 related articles for article (PubMed ID: 19653878)
1. Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.
Barber-Singh J; Seo BB; Nakamaru-Ogiso E; Lau YS; Matsuno-Yagi A; Yagi T
Rejuvenation Res; 2009 Aug; 12(4):259-67. PubMed ID: 19653878
[TBL] [Abstract][Full Text] [Related]
2. In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Matsuno-Yagi A; Yagi T
J Biol Chem; 2006 May; 281(20):14250-5. PubMed ID: 16543240
[TBL] [Abstract][Full Text] [Related]
3. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
5. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
[TBL] [Abstract][Full Text] [Related]
6. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
7. Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease.
Xiao-Feng L; Wen-Ting Z; Yuan-Yuan X; Chong-Fa L; Lu Z; Jin-Jun R; Wen-Ya W
Eur J Pharmacol; 2016 Nov; 791():348-354. PubMed ID: 27614126
[TBL] [Abstract][Full Text] [Related]
8. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
9. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.
Marella M; Seo BB; Nakamaru-Ogiso E; Greenamyre JT; Matsuno-Yagi A; Yagi T
PLoS One; 2008 Jan; 3(1):e1433. PubMed ID: 18197244
[TBL] [Abstract][Full Text] [Related]
10. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
Fujita A; Fujita Y; Pu Y; Chang L; Hashimoto K
Psychopharmacology (Berl); 2020 Jan; 237(1):83-92. PubMed ID: 31418048
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for complex I deficiencies.
Seo BB; Nakamaru-Ogiso E; Cruz P; Flotte TR; Yagi T; Matsuno-Yagi A
Hum Gene Ther; 2004 Sep; 15(9):887-95. PubMed ID: 15353043
[TBL] [Abstract][Full Text] [Related]
12. Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Kao MC; Matsuno-Yagi A
Rejuvenation Res; 2006; 9(2):191-7. PubMed ID: 16706641
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
15. Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of parkinsonism with severe neurodegeneration.
Al-Jarrah M; Pothakos K; Novikova L; Smirnova IV; Kurz MJ; Stehno-Bittel L; Lau YS
Neuroscience; 2007 Oct; 149(1):28-37. PubMed ID: 17869432
[TBL] [Abstract][Full Text] [Related]
16. Xenotransplantation of mitochondrial electron transfer enzyme, Ndi1, in myocardial reperfusion injury.
Perry CN; Huang C; Liu W; Magee N; Carreira RS; Gottlieb RA
PLoS One; 2011 Feb; 6(2):e16288. PubMed ID: 21339825
[TBL] [Abstract][Full Text] [Related]
17. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
18. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease.
Zhang L; Huang L; Chen L; Hao D; Chen J
Toxicol Lett; 2013 Oct; 222(2):155-63. PubMed ID: 23911879
[TBL] [Abstract][Full Text] [Related]
20. Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.
Zhu YL; Sun MF; Jia XB; Zhang PH; Xu YD; Zhou ZL; Xu ZH; Cui C; Chen X; Yang XS; Shen YQ
Neuroreport; 2018 Sep; 29(13):1075-1083. PubMed ID: 29985188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
